TAE Technologies
Funding Information
Date | Amount | Type | Funders | Description |
---|---|---|---|---|
September 03, 2020 | In Kind Grant | INFUSE | ||
May 20, 2016 | $375,000,000 | Investment Round | Series F | |
January 01, 2015 | $127,500,000 | Investment Round | Series E | |
February 01, 2013 | $127,000,000 | Investment Round | Series D-2 | |
August 01, 2010 | $50,000,000 | Investment Round | Series D | |
April 26, 2007 | $40,000,000 | Investment Round | Series C-2 | |
November 14, 2005 | $39,413,060 | Investment Round | Series C | |
September 01, 2003 | $6,670,000 | Investment Round | Series B | |
December 13, 2002 | $1,140,000 | Investment Round | Series A-2 | |
September 19, 2001 | $3,790,000 | Investment Round | Series A | |
January 01, 2000 | $1,700,000 | Investment Round | Capitalization | |
Total: | $772,213,060 |
Description
TAE Technologies originally grew out of the physics department at the University of California, Irvine. TAE was founded in 1998 by George Sealy, Harry Hamlin, and Andrew Conrad in Foothill Ranch, California.
TAE's fusion concept is a field-reversed configuration (FRC) and their original goal was to utilize proton boron fusion fuel which has the advantage of generating almost no neutron radiation.
TAE has raised money from venture capital firms, large corporations, government grants, and private investors.
TAE's strategy has evolved over time, from their original, single minded pursuit of proton-boron fusion to a portfolio focused on fusion and fusion adjacent technologies. These include TAE Life Sciences which focuses on neutron boron cancer research.
Projects
Patents
Key Individuals
Michl Binderbauer, CEO
Toshiki Tajima, Chief Science Officer
Artem Smirnov, CTO
Formation Date
1998
Location
Foothill Ranch California USA